Bladder cancer

NEW --- Adjuvant treatment approaches for MIBC

View the PinPoint cases (
) and get feedback

pT2bN2, R0, PD-L1 negative
pT1 high-grade recurrence post-TMT
ypT3N0, R0, PD-L1 positive
pT2bN2, R0, PD-L1 negative, cisplatin-ineligible
ypT3N0, R1, PD-L1 positive
pT2bN0, R0, PD-L1 negative
pTa low-grade recurrence post-TMT